MDLNMedline Inc.
# 81 · $34.09 (-2.26%) · $45.87B · Healthcare
52-week range
High-severity risk signals
The scoring engine flagged these high-severity signals. They are warnings to investigate and are not part of the score.
- Altman Z in distress zone
Market data
- P/E
- 85.22
- 1M
- -1.64%
- 1Y
- —
- Yield
- —
- RSI
- 34.76
- MACD
- -0.47%
Breakdown
Why
- earnings growth of 262.0% (inflated by an unusually low prior year)
- revenue growth of 11.6%
- EPS vs. estimates: +32.7% on average
Rationale is generated by the scoring engine (English).
Altman Z-Score
Risk signals
- Altman Z in distress zoneHigh
Z-Score 1.51 (< 1.81) — financial distress risk per the Altman model
- Geographic revenue concentrationInfo
93% of revenue from United States
Company research
Business Overview Medline Inc. (NASDAQ: MDLN) is a medical and surgical supplies manufacturer and distributor providing a broad portfolio of med-surg products, clinical solutions, and supply chain services to healthcare providers and other channels, monetized primarily via B2B product sales (often under contract) and related distribution/service revenue. Market Position Medline is a scaled, vertically integrated player in the med-surg supply market, differentiated by its breadth of assortment, manufacturing + distribution footprint, and logistics capabilities that support high service levels across multiple sites of care. Key Segments Key activity clusters include provider-focused med-surg and clinical solutions (e.g., surgical and frontline care consumables), lab/diagnostics-related supplies, and supply chain/logistics services supporting hospital systems, post-acute providers, and other care settings.
AI-generated summary based on third-party data; it may contain errors. Not investment advice or a recommendation to invest.
Period: 2023-12-31 → 2025-12-31
A dash (—) means the figure is not available for that period, not that it is zero. Nothing here is estimated or filled in.